Alliance Pharmaceuticals Limited Revenue and Competitors

Chippenham, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Alliance Pharmaceuticals Limited's estimated annual revenue is currently $121.8M per year.(i)
  • Alliance Pharmaceuticals Limited's estimated revenue per employee is $201,000

Employee Data

  • Alliance Pharmaceuticals Limited has 606 Employees.(i)
  • Alliance Pharmaceuticals Limited grew their employee count by 4% last year.

Alliance Pharmaceuticals Limited's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Marketing & E-Commerce (North America)Reveal Email/Phone
3
Parient Safety Officer (Pharmacovigilance and healthcare product vigilance)Reveal Email/Phone
4
Head Global Brand ProtectionReveal Email/Phone
5
Head Technical and DevelopmentReveal Email/Phone
6
Head Investor Relations and Corporate CommunicationsReveal Email/Phone
7
Head Global MarketingReveal Email/Phone
8
Head Scientific Affairs, Research & DevelopmentReveal Email/Phone
9
Head Global eCommerceReveal Email/Phone
10
Head Corporate DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Alliance Pharmaceuticals Limited?

Alliance is a publicly owned international pharmaceutical company listed on AIM, part of the London Stock Exchange. We started trading in 1998 and have grown strongly to an annual turnover over £100 million. At the heart of our business sits a diverse team of dedicated, enthusiastic and experienced professionals who are committed to providing much needed medicines around the world. Our expertise lies in the acquisition and licensing of pharmaceutical and healthcare products and delivering these to patients. We look carefully for certain criteria in these products and select for a blend of underlying sales stability and growth potential. More information can be found in Our Deal History. Capital intensive activities such as manufacturing, warehousing and logistics are outsourced to class leading specialists in these fields. We distribute our products through wholesalers, retail pharmacies, hospitals and a well-respected international network of distributors. Our modern offices are located in the market town of Chippenham, Wiltshire, 70 minutes from central London by direct train. We also have offices in Paris, Milan, Madrid, Düsseldorf, Dublin, Shanghai and Singapore. Adverse Event Reporting Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Pharmacovigilance at Alliance Pharmaceuticals (tel: 01249 466966, email: pharmacovigilance@alliancepharma.co.uk)

keywords:N/A

N/A

Total Funding

606

Number of Employees

$121.8M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alliance Pharmaceuticals Limited News

2022-04-20 - Byrne registers to lobby- POLITICO

Acg Advocacy: Bsa Business Software Alliance, Inc. ... Brownstein Hyatt Farber Schreck, LLP: Aipharma Global Holdings Limited

2022-04-19 - Medicare's aggressive approach to CKD attracts providers ...

... hypertension and, in some cases, limited access to care. ... New pharmaceuticals that not only treat the underlying conditions of...

2021-09-21 - Alliance Pharma : (427KB)

Alliance Pharma plc For immediate release 21 September 2021 ALLIANCE PHARMA PLC ("Alliance" or the "Group") Interim results for the six months ended 30 June 2021 Strong growth from Consumer Healthcare brands and integration of Amberen complete Full year outlook in line with market expecta ...

2021-09-21 - Alliance Pharma : Interim Results for the year ended 30 June 2021

Interim Results for the year ended 30 June 2021 Strong growth from Consumer Healthcare brands and integration of Amberen complete Full year outlook in line with market expectations Alliance Pharma plc (AIM: APH), the international healthcare group, announces its interim results for the six mo ...

2021-09-21 - Alliance Pharma : (2.0MB)

Alliance Pharma plc Half Year Report 2021 Together     we achieve more An alliance of people, partners and brands, working together to achieve more Contents 2021 H1 Overview & 01 Unaudited Consolidated 14 Financial Highlights Balance Sheet Chief Executive's Review 02 Unaudited Con ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M12448%N/A
#2
$3305M77405%N/A